Vivek Kumar Garripelli

Vivek Kumar Garripelli currently serves as Director at Ultragenyx since March 2021, specializing in formulation and drug product process development for mRNA and lipid nanoparticles. Prior to this, Vivek held various roles at AbbVie from September 2012 to March 2021, including Associate Director and Principal Research Scientist, focusing on dosage form development for protein therapeutics and ensuring project deliverables through cross-functional collaboration. Experience also includes a role as Contract Associate Scientist at Genentech-Roche, where Vivek contributed to drug delivery systems and evaluated polymer-based delivery methods. Education includes a Ph.D. in Pharmaceutics from The University of Mississippi and a BS in Pharmacy from Kakatiya University.